Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15:417-418; doi:10.1136/tc.2006.018887
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bero, L A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bero, L A

EDITORIAL

Clinical trials

Clinical trial registration at Tobacco Control

L A Bero

Correspondence to:
Professor Lisa A Bero
Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, San Francisco, CA 94143-0936, USA; berol@pharmacy.ucsf.edu


Submissions to Tobacco Control—the "ins" and "outs"

The first 150 words of the full text of this article appear below.

Tobacco Control publishes systematic reviews, meta-analyses and clinical trials. The complete and accurate reporting of these trials is crucial to establish the scientific evidence on which sound clinical decisions can be based. Systematic reviews and meta-analyses of randomised controlled trials are the most methodologically rigorous types of evidence to evaluate the effectiveness of therapeutic interventions, particularly pharmacotherapy.1,2 They often form the foundation for practice guidelines, clinical decision support systems, drug formulary decisions and drug payment schemes. However, systematic reviews proceed under the assumption that a complete and representative sample of relevant studies is available for analysis.3 As access to relevant studies is often limited to published studies, systematic reviews and meta-analyses, and, ultimately, practice guidelines and patient care, are particularly vulnerable to biases that may affect publication.


"SCIENTIFIC MISCONDUCT"
One type of publication bias—the publication of study results based on the direction and statistical significance of study findings—poses a . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.